United States Immune Checkpoint Inhibitor Market Report 2016

Market: Pharma & Healthcare

, 0 pages report, published by QYResearch

Report ThumbnailDecember-2016
Notes:
Sales, means the sales volume of Immune Checkpoint Inhibitor
Revenue, means the sales value of Immune Checkpoint Inhibitor

This report studies sales (consumption) of Immune Checkpoint Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bristol-Myers Squibb
Eli Lilly and Company
Merck & Co.
Roche
Taiho Pharmaceutical
Sumitomo Dainippon Pharma
...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Immune Checkpoint Inhibitor in each application, can be divided into
Application 1
Application 2
Application 3

  • List of Tables and Figures
  • Figure Picture of Immune Checkpoint Inhibitor
  • Table Classification of Immune Checkpoint Inhibitor
  • Figure United States Sales Market Share of Immune Checkpoint Inhibitor by Type in 2015
  • Table Application of Immune Checkpoint Inhibitor
  • Figure United States Sales Market Share of Immune Checkpoint Inhibitor by Application in 2015
  • Figure United States Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2021)
  • Figure United States Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
  • Table United States Immune Checkpoint Inhibitor Sales of Key Manufacturers (2015 and 2016)
  • Table United States Immune Checkpoint Inhibitor Sales Share by Manufacturers (2015 and 2016)
  • Figure 2015 Immune Checkpoint Inhibitor Sales Share by Manufacturers
  • Figure 2016 Immune Checkpoint Inhibitor Sales Share by Manufacturers
  • Table United States Immune Checkpoint Inhibitor Revenue by Manufacturers (2015 and 2016)
  • Table United States Immune Checkpoint Inhibitor Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 United States Immune Checkpoint Inhibitor Revenue Share by Manufacturers
  • Table 2016 United States Immune Checkpoint Inhibitor Revenue Share by Manufacturers
  • Table United States Market Immune Checkpoint Inhibitor Average Price of Key Manufacturers (2015 and 2016)
  • Figure United States Market Immune Checkpoint Inhibitor Average Price of Key Manufacturers in 2015
  • Figure Immune Checkpoint Inhibitor Market Share of Top 3 Manufacturers
  • Figure Immune Checkpoint Inhibitor Market Share of Top 5 Manufacturers
  • Table United States Immune Checkpoint Inhibitor Sales by Type (2011-2016)
  • Table United States Immune Checkpoint Inhibitor Sales Share by Type (2011-2016)
  • Figure United States Immune Checkpoint Inhibitor Sales Market Share by Type in 2015
  • Table United States Immune Checkpoint Inhibitor Revenue and Market Share by Type (2011-2016)
  • Table United States Immune Checkpoint Inhibitor Revenue Share by Type (2011-2016)
  • Figure Revenue Market Share of Immune Checkpoint Inhibitor by Type (2011-2016)
  • Table United States Immune Checkpoint Inhibitor Price by Type (2011-2016)
  • Figure United States Immune Checkpoint Inhibitor Sales Growth Rate by Type (2011-2016)
  • Table United States Immune Checkpoint Inhibitor Sales by Application (2011-2016)
  • Table United States Immune Checkpoint Inhibitor Sales Market Share by Application (2011-2016)
  • Figure United States Immune Checkpoint Inhibitor Sales Market Share by Application in 2015
  • Table United States Immune Checkpoint Inhibitor Sales Growth Rate by Application (2011-2016)
  • Figure United States Immune Checkpoint Inhibitor Sales Growth Rate by Application (2011-2016)
  • Table Bristol-Myers Squibb Basic Information List
  • Table Bristol-Myers Squibb Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Figure Bristol-Myers Squibb Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Eli Lilly and Company Basic Information List
  • Table Eli Lilly and Company Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Eli Lilly and Company Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Merck & Co. Basic Information List
  • Table Merck & Co. Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Merck & Co. Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Roche Basic Information List
  • Table Roche Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Roche Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Taiho Pharmaceutical Basic Information List
  • Table Taiho Pharmaceutical Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Taiho Pharmaceutical Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Sumitomo Dainippon Pharma Basic Information List
  • Table Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Sales Market Share (2011-2016)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Immune Checkpoint Inhibitor
  • Figure Manufacturing Process Analysis of Immune Checkpoint Inhibitor
  • Figure Immune Checkpoint Inhibitor Industrial Chain Analysis
  • Table Raw Materials Sources of Immune Checkpoint Inhibitor Major Manufacturers in 2015
  • Table Major Buyers of Immune Checkpoint Inhibitor
  • Table Distributors/Traders List
  • Figure United States Immune Checkpoint Inhibitor Production and Growth Rate Forecast (2016-2021)
  • Figure United States Immune Checkpoint Inhibitor Revenue and Growth Rate Forecast (2016-2021)
  • Table United States Immune Checkpoint Inhibitor Production Forecast by Type (2016-2021)
  • Table United States Immune Checkpoint Inhibitor Consumption Forecast by Application (2016-2021)
  • Table of Contents
  • United States Immune Checkpoint Inhibitor Market Report 2016
  • 1 Immune Checkpoint Inhibitor Overview
  • 1.1 Product Overview and Scope of Immune Checkpoint Inhibitor
  • 1.2 Classification of Immune Checkpoint Inhibitor
  • 1.2.1 Type I
  • 1.2.2 Type II
  • 1.2.3 Type III
  • 1.3 Application of Immune Checkpoint Inhibitor
  • 1.3.1 Application 1
  • 1.3.2 Application 2
  • 1.3.3 Application 3
  • 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Immune Checkpoint Inhibitor (2011-2021)
  • 1.4.1 United States Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2021)
  • 1.4.2 United States Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
  • 2 United States Immune Checkpoint Inhibitor Competition by Manufacturers
  • 2.1 United States Immune Checkpoint Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
  • 2.2 United States Immune Checkpoint Inhibitor Revenue and Share by Manufactures (2015 and 2016)
  • 2.3 United States Immune Checkpoint Inhibitor Average Price by Manufactures (2015 and 2016)
  • 2.4 Immune Checkpoint Inhibitor Market Competitive Situation and Trends
  • 2.4.1 Immune Checkpoint Inhibitor Market Concentration Rate
  • 2.4.2 Immune Checkpoint Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  • 2.4.3 Mergers & Acquisitions, Expansion
  • 3 United States Immune Checkpoint Inhibitor Sales (Volume) and Revenue (Value) by Type (2011-2016)
  • 3.1 United States Immune Checkpoint Inhibitor Sales and Market Share by Type (2011-2016)
  • 3.2 United States Immune Checkpoint Inhibitor Revenue and Market Share by Type (2011-2016)
  • 3.3 United States Immune Checkpoint Inhibitor Price by Type (2011-2016)
  • 3.4 United States Immune Checkpoint Inhibitor Sales Growth Rate by Type (2011-2016)
  • 4 United States Immune Checkpoint Inhibitor Sales (Volume) by Application (2011-2016)
  • 4.1 United States Immune Checkpoint Inhibitor Sales and Market Share by Application (2011-2016)
  • 4.2 United States Immune Checkpoint Inhibitor Sales Growth Rate by Application (2011-2016)
  • 4.3 Market Drivers and Opportunities
  • 5 United States Immune Checkpoint Inhibitor Manufacturers Profiles/Analysis
  • 5.1 Bristol-Myers Squibb
  • 5.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 5.1.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.1.2.1 Type I
  • 5.1.2.2 Type II
  • 5.1.3 Bristol-Myers Squibb Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.1.4 Main Business/Business Overview
  • 5.2 Eli Lilly and Company
  • 5.2.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.2.2.1 Type I
  • 5.2.2.2 Type II
  • 5.2.3 Eli Lilly and Company Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.2.4 Main Business/Business Overview
  • 5.3 Merck & Co.
  • 5.3.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.3.2.1 Type I
  • 5.3.2.2 Type II
  • 5.3.3 Merck & Co. Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.3.4 Main Business/Business Overview
  • 5.4 Roche
  • 5.4.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.4.2.1 Type I
  • 5.4.2.2 Type II
  • 5.4.3 Roche Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.4.4 Main Business/Business Overview
  • 5.5 Taiho Pharmaceutical
  • 5.5.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.5.2.1 Type I
  • 5.5.2.2 Type II
  • 5.5.3 Taiho Pharmaceutical Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.5.4 Main Business/Business Overview
  • 5.6 Sumitomo Dainippon Pharma
  • 5.6.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
  • 5.6.2.1 Type I
  • 5.6.2.2 Type II
  • 5.6.3 Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.6.4 Main Business/Business Overview
  • ...
  • 6 Immune Checkpoint Inhibitor Manufacturing Cost Analysis
  • 6.1 Immune Checkpoint Inhibitor Key Raw Materials Analysis
  • 6.1.1 Key Raw Materials
  • 6.1.2 Price Trend of Key Raw Materials
  • 6.1.3 Key Suppliers of Raw Materials
  • 6.1.4 Market Concentration Rate of Raw Materials
  • 6.2 Proportion of Manufacturing Cost Structure
  • 6.2.1 Raw Materials
  • 6.2.2 Labor Cost
  • 6.2.3 Manufacturing Expenses
  • 6.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitor
  • 7 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 7.1 Immune Checkpoint Inhibitor Industrial Chain Analysis
  • 7.2 Upstream Raw Materials Sourcing
  • 7.3 Raw Materials Sources of Immune Checkpoint Inhibitor Major Manufacturers in 2015
  • 7.4 Downstream Buyers
  • 8 Marketing Strategy Analysis, Distributors/Traders
  • 8.1 Marketing Channel
  • 8.1.1 Direct Marketing
  • 8.1.2 Indirect Marketing
  • 8.1.3 Marketing Channel Development Trend
  • 8.2 Market Positioning
  • 8.2.1 Pricing Strategy
  • 8.2.2 Brand Strategy
  • 8.2.3 Target Client
  • 8.3 Distributors/Traders List
  • 9 Market Effect Factors Analysis
  • 9.1 Technology Progress/Risk
  • 9.1.1 Substitutes Threat
  • 9.1.2 Technology Progress in Related Industry
  • 9.2 Consumer Needs/Customer Preference Change
  • 9.3 Economic/Political Environmental Change
  • 10 United States Immune Checkpoint Inhibitor Market Forecast (2016-2021)
  • 10.1 United States Immune Checkpoint Inhibitor Sales, Revenue Forecast (2016-2021)
  • 10.2 United States Immune Checkpoint Inhibitor Sales Forecast by Type (2016-2021)
  • 10.3 United States Immune Checkpoint Inhibitor Sales Forecast by Application (2016-2021)
  • 10.4 Immune Checkpoint Inhibitor Price Forecast (2016-2021)
  • 11 Research Findings and Conclusion
  • 12 Appendix
  • Disclosure Section
  • Research Methodology
  • Data Source
  • Disclaimer

Please select a license type

Share

Related Products

QYResearchUnited States Immune Checkpoint Inhibitor Market Report 2016 Product ThumbnailUnited States Immune Checkpoint Inhibitor Market Report 2016 , Industry ReportProduct #: 618463
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved